Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
11/2005
11/09/2005EP1593674A1 Optically active bisoxazoline compounds, process for production of the same and use thereof
11/09/2005EP1593667A1 Amine derivative
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1592665A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/09/2005EP1592656A2 Medicinal compounds
11/09/2005EP1226113B1 Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1206427B1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions
11/09/2005EP1149066B1 Method of preparing alkylated salicylamides
11/09/2005EP1042275B1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
11/09/2005CN1694869A Substituted spirocyclic ketoenols
11/09/2005CN1694865A Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
11/09/2005CN1694863A Compound protecting against ultraviolet
11/09/2005CN1226295C Preparation method of important intermediate for mosapride citrate
11/09/2005CN1226279C Recovery method of heavily polluted substance produced in ADC foaming agent production process
11/09/2005CN1226277C Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
11/09/2005CN1226276C Extraction of natural capsaicine
11/09/2005CN1225972C Fungicidal compositions based on (N-phenylacetyl-N-2,6-xylyl) alaninate
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/03/2005WO2005103280A1 Process for producing optically active 4-(n-protected amino)-1-alken-3-ol and process for producing therefrom 3-benzamido-2-hydroxycarboxylic acid or salt thereof
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
11/03/2005WO2005080316A3 Modulators of cannabinoid receptors
11/03/2005WO2005079541A3 Terephthalamide peptidomimetic compounds and methods
11/03/2005US20050245616 Ketoamine tumor suppressor reactivators: 3-Acetoxy-2-(acetoxymethyl)-1-oxo-1-phenylpropan-2-ammonium chloride
11/03/2005US20050245583 Pesticides for crops; agriculture, horticulture
11/03/2005US20050245408 Sustained release; controlled chemical cascade; storage stability
11/02/2005EP1591440A1 Alanines compounds, method of preparing them and their use
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1370516B1 Quaternary surfactants
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP1157000B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/02/2005EP1100443B1 Hair treatment preparation
11/02/2005CN1690045A Process for synthesizing aryl substituted N-aryl amide compounds
11/02/2005CN1690044A 5, 8-menadiol diacetate derivatives and their preparing process and use
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/02/2005CN1225457C Phosphine reduction method for converting azide into amide
11/01/2005US6960689 Method for preparing nitrogen-containing compounds
11/01/2005US6960588 Tryptase inhibitors
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
11/01/2005CA2177586C 4-benzoylisoxazoles and their use as herbicides
10/2005
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005WO2005100297A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005070866A3 Polymer dispersions or solutions comprising 3,4 dihydroxyphenyl groups
10/27/2005WO2005063687A3 New process for the synthesis of eneamide derivatives
10/27/2005US20050240007 Ferrocenyl ligands and method for the production of such ligands
10/27/2005US20050239898 Compounds for use in the treatment of aids and other viral diseases and HIV-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239204 Multifunctional molecular complexes for gene transfer to cells
10/27/2005CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587783A2 Cycloalkyl containing anilide ligands for the thyroid receptor
10/26/2005EP1587506A2 Administration of capsaicinoids
10/26/2005EP0973727B1 Activated iododerivatives for the treatment of cancer and aids
10/26/2005CN1688541A Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
10/26/2005CN1224697C Process for preparation of amino alcohols and derivatives thereof
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005USRE38856 with ultra low salt content; from a highly acidic hot triiodination by increasing the pH with a base, adding seed crystals, cooling slowly, and washing the collected precipitate; making iohexol for example
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958243 Organic reactions with CO generating materials
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2005CA2157191C Process for the hydrogenation of imines
10/20/2005WO2005097868A1 Esteramide compositions, copolymers and blends thereof
10/20/2005WO2005097773A1 1,1’-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/20/2005WO2005097735A1 Physiological cooling compositions containing highly purified ethyl ester of n-[[5-methyl-2-(1-methylethyl)cyclohexyl)carbonyl]glycine
10/20/2005WO2005044191A3 Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
10/20/2005US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia
10/20/2005US20050234253 bidentate organophosphorous ferrocenyl ligands that create a highly asymmetric coordination sphere
10/20/2005US20050234132 pleasant extremely pungent and warm flavor reminiscent of ethanol, relatively long lasting; heat-generating effect for foodstuffs, spice mix, oral hygiene, perfume; lipase enzymatic amidation of 2,4-decadienoic acid ester with isobutylamine; simple process, very pure product isomer
10/20/2005US20050234131 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
10/20/2005US20050234129 Salts of nateglinide
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050233042 Flavourant compounds
10/20/2005CA2560648A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/19/2005EP1586556A2 Compounds to treat Alzheimer's disease
10/19/2005EP1586552A1 Process for producing benzylamine derivative
10/19/2005EP1585757A2 Peptide deformylase inhibitors
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585735A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1551522A4 Purification of n,n-dimethylacetamide
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/19/2005CN1684582A Improved synthesis of polyanhydrides
10/19/2005CN1223578C Medical compound with antalgic, anti-inflammation and thrombocyte decoagulation function
10/18/2005US6956059 use in relief of rheumatoid arthritis, rheumatoid spondylitis, osteroarthritis, gouty arthritis and other arthritic conditions, inflamed joints, eczema and other inflammatory skin conditions, inflammatory eye conditions, aids, hiv
10/18/2005US6956014 Thickener
10/13/2005WO2005095328A1 Chemical process and new crystalline form
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005WO2005095325A1 PROCESS FOR THE PREPARATION OF β-AMINOCARBOXYLIC ACIDS
10/13/2005WO2005095320A1 Preparation of acrylic acid derivatives from alpha or beta-hydroxy carboxylic acids
10/13/2005WO2005094323A2 Process for preparing a dipeptidyl peptidase iv inhibitor and intermediates employed therein
10/13/2005US20050228190 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
10/13/2005US20050228186 Simple stereocontrolled synthesis of salinosporamide A
10/13/2005US20050228122 Esteramide compositions, copolymers and blends thereof
10/13/2005US20050228017 Novel anticancer compounds
10/13/2005US20050227990 Aminoalkoxy-functional chalcones
1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 289